174 related articles for article (PubMed ID: 29064403)
1. Characterization of Three Ocular Clinical Isolates of P. aeruginosa: Viability, Biofilm Formation, Adherence, Infectivity, and Effects of Glycyrrhizin.
Peng X; Ekanayaka SA; McClellan SA; Barrett RP; Vistisen K; Hazlett LD
Pathogens; 2017 Oct; 6(4):. PubMed ID: 29064403
[TBL] [Abstract][Full Text] [Related]
2. Glycyrrhizin Reduces HMGB1 and Bacterial Load in Pseudomonas aeruginosa Keratitis.
Ekanayaka SA; McClellan SA; Barrett RP; Kharotia S; Hazlett LD
Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5799-5809. PubMed ID: 27792814
[TBL] [Abstract][Full Text] [Related]
3. Topical Glycyrrhizin Is Therapeutic for Pseudomonas aeruginosa Keratitis.
Ekanayaka SA; McClellan SA; Barrett RP; Hazlett LD
J Ocul Pharmacol Ther; 2018 Apr; 34(3):239-249. PubMed ID: 29236588
[TBL] [Abstract][Full Text] [Related]
4. Glycyrrhizin Use for Multi-Drug Resistant Pseudomonas aeruginosa: In Vitro and In Vivo Studies.
Hazlett LD; Ekanayaka SA; McClellan SA; Francis R
Invest Ophthalmol Vis Sci; 2019 Jul; 60(8):2978-2989. PubMed ID: 31311033
[TBL] [Abstract][Full Text] [Related]
5. Effects of Glycyrrhizin on Multi-Drug Resistant
Carruthers NJ; McClellan SA; Somayajulu M; Pitchaikannu A; Bessert D; Peng X; Huitsing K; Stemmer PM; Hazlett LD
Pathogens; 2020 Sep; 9(9):. PubMed ID: 32962036
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of biofilm production and characterization of genes encoding type III secretion system among Pseudomonas aeruginosa isolated from burn patients.
Jabalameli F; Mirsalehian A; Khoramian B; Aligholi M; Khoramrooz SS; Asadollahi P; Taherikalani M; Emaneini M
Burns; 2012 Dec; 38(8):1192-7. PubMed ID: 22995427
[TBL] [Abstract][Full Text] [Related]
7. Glycyrrhizin Interacts with TLR4 and TLR9 to Resolve
Somayajulu M; McClellan SA; Farooq SM; Pitchaikannu A; Xu S; Hazlett L
Pathogens; 2022 Nov; 11(11):. PubMed ID: 36422579
[TBL] [Abstract][Full Text] [Related]
8. Presence of exoY, exoS, exoU and exoT genes, antibiotic resistance and biofilm production among Pseudomonas aeruginosa isolates in Northwest Iran.
Azimi S; Kafil HS; Baghi HB; Shokrian S; Najaf K; Asgharzadeh M; Yousefi M; Shahrivar F; Aghazadeh M
GMS Hyg Infect Control; 2016; 11():Doc04. PubMed ID: 26958458
[TBL] [Abstract][Full Text] [Related]
9. Silencing Toll-like receptor-9 in Pseudomonas aeruginosa keratitis.
Huang X; Barrett RP; McClellan SA; Hazlett LD
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4209-16. PubMed ID: 16249500
[TBL] [Abstract][Full Text] [Related]
10. High-mobility group box 1: a novel target for treatment of Pseudomonas aeruginosa keratitis.
McClellan S; Jiang X; Barrett R; Hazlett LD
J Immunol; 2015 Feb; 194(4):1776-87. PubMed ID: 25589066
[TBL] [Abstract][Full Text] [Related]
11. Genetic features of Pseudomonas aeruginosa isolates associated with eye infections referred to Farabi Hospital, Tehran, Iran.
Doustdar F; Karimi F; Abedinyfar Z; Amoli FA; Goudarzi H
Int Ophthalmol; 2019 Jul; 39(7):1581-1587. PubMed ID: 29982958
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of Pseudomonas aeruginosa related to bovine mastitis.
Park HR; Hong MK; Hwang SY; Park YK; Kwon KH; Yoon JW; Shin S; Kim JH; Park YH
Acta Vet Hung; 2014 Mar; 62(1):1-12. PubMed ID: 24334080
[TBL] [Abstract][Full Text] [Related]
13. Comparison of virulence factors in Pseudomonas aeruginosa strains isolated from contact lens- and non-contact lens-related keratitis.
Choy MH; Stapleton F; Willcox MDP; Zhu H
J Med Microbiol; 2008 Dec; 57(Pt 12):1539-1546. PubMed ID: 19018027
[TBL] [Abstract][Full Text] [Related]
14. Ocular Effects of Glycyrrhizin at Acidic and Neutral pH.
Somayajulu M; McClellan SA; Bessert DA; Pitchaikannu A; Hazlett LD
Front Cell Infect Microbiol; 2021; 11():782063. PubMed ID: 35127554
[TBL] [Abstract][Full Text] [Related]
15. ExoU expression by Pseudomonas aeruginosa correlates with acute cytotoxicity and epithelial injury.
Finck-Barbançon V; Goranson J; Zhu L; Sawa T; Wiener-Kronish JP; Fleiszig SM; Wu C; Mende-Mueller L; Frank DW
Mol Microbiol; 1997 Aug; 25(3):547-57. PubMed ID: 9302017
[TBL] [Abstract][Full Text] [Related]
16. Characterization of virulence factors, antimicrobial resistance patterns and biofilm formation of Pseudomonas aeruginosa and Staphylococcus spp. strains isolated from corneal infection.
Heidari H; Hadadi M; Sedigh Ebrahim-Saraie H; Mirzaei A; Taji A; Hosseini SR; Motamedifar M
J Fr Ophtalmol; 2018 Nov; 41(9):823-829. PubMed ID: 30292385
[TBL] [Abstract][Full Text] [Related]
17. Relationship of Virulence Factors and Clinical Features in Keratitis Caused by Pseudomonas aeruginosa.
Oka N; Suzuki T; Ishikawa E; Yamaguchi S; Hayashi N; Gotoh N; Ohashi Y
Invest Ophthalmol Vis Sci; 2015 Oct; 56(11):6892-8. PubMed ID: 26517406
[TBL] [Abstract][Full Text] [Related]
18. Effect of nano-silver, nano-copper, deconex and benzalkonium chloride on biofilm formation and expression of transcription regulatory quorum sensing gene (rh1R) in drug-resistance Pseudomonas aeruginosa burn isolates.
Gholamrezazadeh M; Shakibaie MR; Monirzadeh F; Masoumi S; Hashemizadeh Z
Burns; 2018 May; 44(3):700-708. PubMed ID: 29290510
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of type III secretion genes in clinical and environmental isolates of Pseudomonas aeruginosa.
Feltman H; Schulert G; Khan S; Jain M; Peterson L; Hauser AR
Microbiology (Reading); 2001 Oct; 147(Pt 10):2659-2669. PubMed ID: 11577145
[TBL] [Abstract][Full Text] [Related]
20. ST2 is essential for Th2 responsiveness and resistance to pseudomonas aeruginosa keratitis.
Huang X; Du W; Barrett RP; Hazlett LD
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4626-33. PubMed ID: 17898286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
